MIU
TECH icon

Man Investments (UK)’s Bio-Techne TECH Stock Holding History

Man Investments (UK)’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-56,008
Closed -$1.12M – 677
2013
Q3 		$1.12M Buy
+56,008
New +$1.06M 0.15% 280

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Man Investments (UK)'s TECH Position: Q4 2013 in Review

Man Investments (UK) sold out of Bio-Techne (TECH) in Q4 2013, closing a stake of 56,008 shares — an estimated $1.12M sold.

Man Investments (UK) first reported a position in TECH in Q3 2013 and held it in 1 quarter. The position peaked at $1.12M in Q3 2013. 245 funds tracked by Wall St. Rank hold TECH as of Q4 2013.

  • Man Investments (UK) reported no remaining Bio-Techne position as of Q4 2013 after selling out during the quarter.
  • Man Investments (UK) sold 56,008 Bio-Techne shares in Q4 2013, an estimated $1.12M.
  • Man Investments (UK) first reported a position in Bio-Techne in Q3 2013 and held it in 1 quarter.
  • Man Investments (UK)'s Bio-Techne position peaked at $1.12M in Q3 2013.
  • 245 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2013.

Based on Man Investments (UK)'s 13F filing for Q4 2013, filed 14 Feb 2014.